FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4310673650> ?p ?o ?g. }

• W4310673650 abstract "Introduction The pathogenic mechanisms of diabetic nephropathy (DN) include podocyte injury, inflammatory responses and metabolic disorders. Although the antagonism of Angiopoietin-like protein 3 (ANGPTL3) can alleviate proteinuria symptoms by inhibiting the activation of integrin αvβ3 on the surface of podocytes, it can not impede other pathological processes, such as inflammatory responses and metabolic dysfunction of glucolipid. Interleukin-22 (IL-22) is considered to be a pivotal molecule involved in suppressing inflammatory responses, initiating regenerative repair, and regulating glucolipid metabolism. Methods Genes encoding the mIL22IgG2aFc and two chains of anti-ANGPTL3 antibody and bifunctional protein were synthesized. Then, the DN mice were treated with intraperitoneal injection of normal saline, anti-ANGPTL3 (20 mg/kg), mIL22Fc (12 mg/kg) or anti-ANGPTL3 /IL22 (25.3 mg/kg) and irrigation of positive drug losartan (20mg/kg/d) twice a week for 8 weeks. Results In this research, a novel bifunctional fusion protein (anti-ANGPTL3/IL22) formed by the fusion of IL-22 with the C-terminus of anti-ANGPTL3 antibody exhibited favorable stability and maintained the biological activity of anti-ANGPTL3 and IL-22, respectively. The fusion protein showed a more pronounced attenuation of proteinuria and improved dysfunction of glucolipid metabolism compared with mIL22Fc or anti-ANGPTL3. Our results also indicated that anti-ANGPTL3/IL22 intervention significantly alleviated renal fibrosis via inhibiting the expression of the inflammatory response-related protein nuclear factor kappa light-chain enhancer of activated B cells (NF-κB) p65 and NOD-like receptor family pyrin domain-containing protein 3 (NLRP3) inflammasome. Moreover, transcriptome analysis revealed the downregulation of signaling pathways associated with injury and dysfunction of the renal parenchymal cell indicating the possible protective mechanisms of anti-ANGPTL3/IL22 in DN. Conclusion Collectively, anti-ANGPTL3/IL22 bifunctional fusion protein can be a promising novel therapeutic strategy for DN by reducing podocyte injury, ameliorating inflammatory response, and enhancing renal tissue recovery." @default.
• W4310673650 created "2022-12-15" @default.
• W4310673650 creator A5020929464 @default.
• W4310673650 creator A5026154387 @default.
• W4310673650 creator A5031618260 @default.
• W4310673650 creator A5047428609 @default.
• W4310673650 creator A5051500081 @default.
• W4310673650 creator A5052529616 @default.
• W4310673650 creator A5059540588 @default.
• W4310673650 creator A5062559032 @default.
• W4310673650 creator A5063255715 @default.
• W4310673650 creator A5063431190 @default.
• W4310673650 creator A5063470398 @default.
• W4310673650 creator A5068335766 @default.
• W4310673650 creator A5070547367 @default.
• W4310673650 creator A5073267442 @default.
• W4310673650 creator A5078482745 @default.
• W4310673650 creator A5084058732 @default.
• W4310673650 date "2022-12-05" @default.
• W4310673650 modified "2023-10-18" @default.
• W4310673650 title "A novel fusion protein consisting of anti-ANGPTL3 antibody and interleukin-22 ameliorates diabetic nephropathy in mice" @default.
• W4310673650 cites W1905813498 @default.
• W4310673650 cites W1907964358 @default.
• W4310673650 cites W1971604855 @default.
• W4310673650 cites W1975296949 @default.
• W4310673650 cites W1996775227 @default.
• W4310673650 cites W1996854381 @default.
• W4310673650 cites W2006522099 @default.
• W4310673650 cites W2012271345 @default.
• W4310673650 cites W2016351573 @default.
• W4310673650 cites W2020133142 @default.
• W4310673650 cites W2032922327 @default.
• W4310673650 cites W2033200911 @default.
• W4310673650 cites W2040649891 @default.
• W4310673650 cites W2050622384 @default.
• W4310673650 cites W2058282851 @default.
• W4310673650 cites W2059138999 @default.
• W4310673650 cites W2067827338 @default.
• W4310673650 cites W2075089162 @default.
• W4310673650 cites W2075319728 @default.
• W4310673650 cites W2077672077 @default.
• W4310673650 cites W2078608376 @default.
• W4310673650 cites W2085746855 @default.
• W4310673650 cites W2130561540 @default.
• W4310673650 cites W2136160292 @default.
• W4310673650 cites W2138256890 @default.
• W4310673650 cites W2152096085 @default.
• W4310673650 cites W2157230648 @default.
• W4310673650 cites W2159932011 @default.
• W4310673650 cites W2166080653 @default.
• W4310673650 cites W2191038342 @default.
• W4310673650 cites W2293179221 @default.
• W4310673650 cites W2343677729 @default.
• W4310673650 cites W2410592318 @default.
• W4310673650 cites W2415990367 @default.
• W4310673650 cites W2585789979 @default.
• W4310673650 cites W2594651069 @default.
• W4310673650 cites W2608333216 @default.
• W4310673650 cites W2737074341 @default.
• W4310673650 cites W2739003874 @default.
• W4310673650 cites W2765736556 @default.
• W4310673650 cites W2778428592 @default.
• W4310673650 cites W2786711651 @default.
• W4310673650 cites W2894849225 @default.
• W4310673650 cites W2911152151 @default.
• W4310673650 cites W2912673858 @default.
• W4310673650 cites W2915339967 @default.
• W4310673650 cites W2946298601 @default.
• W4310673650 cites W3014721260 @default.
• W4310673650 cites W3040774192 @default.
• W4310673650 cites W3128594661 @default.
• W4310673650 cites W4223547489 @default.
• W4310673650 cites W4242364069 @default.
• W4310673650 cites W3130190431 @default.
• W4310673650 doi "https://doi.org/10.3389/fimmu.2022.1011442" @default.
• W4310673650 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36544775" @default.
• W4310673650 hasPublicationYear "2022" @default.
• W4310673650 type Work @default.
• W4310673650 citedByCount "1" @default.
• W4310673650 countsByYear W43106736502023 @default.
• W4310673650 crossrefType "journal-article" @default.
• W4310673650 hasAuthorship W4310673650A5020929464 @default.
• W4310673650 hasAuthorship W4310673650A5026154387 @default.
• W4310673650 hasAuthorship W4310673650A5031618260 @default.
• W4310673650 hasAuthorship W4310673650A5047428609 @default.
• W4310673650 hasAuthorship W4310673650A5051500081 @default.
• W4310673650 hasAuthorship W4310673650A5052529616 @default.
• W4310673650 hasAuthorship W4310673650A5059540588 @default.
• W4310673650 hasAuthorship W4310673650A5062559032 @default.
• W4310673650 hasAuthorship W4310673650A5063255715 @default.
• W4310673650 hasAuthorship W4310673650A5063431190 @default.
• W4310673650 hasAuthorship W4310673650A5063470398 @default.
• W4310673650 hasAuthorship W4310673650A5068335766 @default.
• W4310673650 hasAuthorship W4310673650A5070547367 @default.
• W4310673650 hasAuthorship W4310673650A5073267442 @default.
• W4310673650 hasAuthorship W4310673650A5078482745 @default.
• W4310673650 hasAuthorship W4310673650A5084058732 @default.
• W4310673650 hasBestOaLocation W43106736501 @default.
• W4310673650 hasConcept C104317684 @default.
• W4310673650 hasConcept C123894998 @default.

• next